News
Gilead is now waiting for regulatory decisions on the twice-yearly PrEP in Europe and other markets, including South Africa ...
A new panel of U.S. vaccine advisers appointed by Health Secretary Robert F. Kennedy Jr. will vote on flu shots that contain ...
A drug currently used to treat certain HIV infections has also, on Wednesday, received approval from the US Food and Drug ...
The drug could change the course of the AIDS epidemic. But the Trump administration has gutted the programs that might have paid for it in low-income countries.
Global shares seesawed on Wednesday as investors await the outcome of key central bank meetings in the US and UK on Wednesday ...
Britain’s FTSE 100 rose on Wednesday as investors weighed the last domestic inflation reading ahead of key central bank ...
The FTSE 100 rose as investors reacted to slower UK inflation and tensions in the Middle East. The Bank of England is ...
GSK PLC GSK shares slid 2.06% to £14.50 Wednesday, on what proved to be an all-around positive trading session for the stock ...
It’s been years since the Cannes Lions International Festival of Creativity awarded its top prize to a traditional ...
GSK stock is up 21.5% in six months, fueled by strong Specialty Medicines growth and a promising pipeline despite vaccine ...
Investing.com -- Shares of AstraZeneca (ST: AZN) and GlaxoSmithKline (LON: GSK) fell Tuesday after former U.S. President ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results